Regencell Bioscience Holdings Limited Ordinary Shares
Market Cap
11B
Short interest (May 15)
0.2%
Net Short (Jun 03 ): 0.0%
Borrow Fee
326.70%
↓ 11.6%
Available Shares
1K
↑ 752.4%
Price Chart
Company Overview
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.